Julie L. Prior

5.5k total citations · 1 hit paper
63 papers, 4.1k citations indexed

About

Julie L. Prior is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Julie L. Prior has authored 63 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 28 papers in Oncology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Julie L. Prior's work include Virus-based gene therapy research (8 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Drug Transport and Resistance Mechanisms (8 papers). Julie L. Prior is often cited by papers focused on Virus-based gene therapy research (8 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Drug Transport and Resistance Mechanisms (8 papers). Julie L. Prior collaborates with scholars based in United States, Ireland and United Kingdom. Julie L. Prior's co-authors include David Piwnica‐Worms, Gary D. Luker, John F. DiPersio, Julie Ritchey, Joel R. Garbow, Vijay Sharma, Matthew C. Smith, Kathryn E. Luker, Erin Jackson and Matthew Holt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Blood.

In The Last Decade

Julie L. Prior

63 papers receiving 4.0k citations

Hit Papers

CXCR4 Regulates Growth of Both Primary and Metastatic Bre... 2004 2026 2011 2018 2004 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer
    2004 586 citations Julie L. Prior, David Piwnica‐Worms et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie L. Prior United States 33 1.8k 1.5k 1.0k 702 352 63 4.1k
Natarajan Muthusamy United States 40 2.3k 1.2× 1.3k 0.8× 2.0k 2.0× 649 0.9× 317 0.9× 177 5.3k
Pu Zhang China 36 3.1k 1.7× 992 0.7× 1.5k 1.5× 2.2k 3.1× 342 1.0× 163 6.5k
Susan D. Spencer United States 24 2.0k 1.1× 1.7k 1.1× 862 0.9× 1.1k 1.5× 141 0.4× 36 5.5k
Jie Sun China 31 1.9k 1.0× 1.4k 0.9× 678 0.7× 169 0.2× 751 2.1× 143 4.1k
Michele Cilli Italy 37 2.0k 1.1× 933 0.6× 658 0.7× 165 0.2× 439 1.2× 108 4.0k
Constantin N. Baxevanis Greece 41 1.9k 1.0× 2.2k 1.4× 3.4k 3.4× 343 0.5× 259 0.7× 158 6.5k
Jamison L. Nourse United States 24 2.9k 1.6× 1.3k 0.9× 467 0.5× 356 0.5× 325 0.9× 36 4.5k
Kei Tashiro Japan 36 2.6k 1.4× 1.7k 1.1× 2.2k 2.2× 365 0.5× 116 0.3× 105 6.4k
William G. Kerr United States 34 2.3k 1.3× 1.2k 0.8× 2.4k 2.4× 650 0.9× 68 0.2× 109 5.2k
David Naor Israel 29 2.0k 1.1× 846 0.6× 1.3k 1.3× 305 0.4× 150 0.4× 136 4.3k

Countries citing papers authored by Julie L. Prior

Since Specialization
Citations

This map shows the geographic impact of Julie L. Prior's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie L. Prior with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie L. Prior more than expected).

Fields of papers citing papers by Julie L. Prior

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie L. Prior. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie L. Prior. The network helps show where Julie L. Prior may publish in the future.

Co-authorship network of co-authors of Julie L. Prior

This figure shows the co-authorship network connecting the top 25 collaborators of Julie L. Prior. A scholar is included among the top collaborators of Julie L. Prior based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie L. Prior. Julie L. Prior is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Lei, Julie L. Prior, Brad Manion, et al.. (2024). Cancer-targeted pro-theranostic bi-metallic organo-coordination nanoparticles. Theranostics. 15(4). 1205–1220. 5 indexed citations
2.
Cheng, Xiaoqing, Maureen Highkin, Xiaohua Jin, et al.. (2023). Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance. Cancer Research. 83(17). 2839–2857. 17 indexed citations
3.
Kim, Sena, Boram Kim, Julie Ritchey, et al.. (2022). S100A9 upregulated by IFNGR signaling blockade functions as a novel GVHD suppressor without compromising GVL in mice. Blood. 141(8). 945–950. 1 indexed citations
4.
O’Neal, Julie, Julie Ritchey, Matthew Cooper, et al.. (2022). CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells. Leukemia. 36(6). 1625–1634. 34 indexed citations
5.
Cho, Hyunah, Udayabhanu Jammalamadaka, Karthik Tappa, et al.. (2019). 3D Printing of Poloxamer 407 Nanogel Discs and Their Applications in Adjuvant Ovarian Cancer Therapy. Molecular Pharmaceutics. 16(2). 552–560. 45 indexed citations
6.
Dhavale, Dhruva D., Julie L. Prior, Ping Yan, et al.. (2016). Fluselenamyl: A Novel Benzoselenazole Derivative for PET Detection of Amyloid Plaques (Aβ) in Alzheimer’s Disease. Scientific Reports. 6(1). 35636–35636. 34 indexed citations
7.
Rettig, Michael P., Matthew Holt, Julie L. Prior, et al.. (2013). Inhibition Of Nuclear Transport Modulator Xpo1/CRM1 For The Treatment Of Acute Myeloid Leukemia (AML). Blood. 122(21). 237–237. 4 indexed citations
8.
Pazolli, Ermira, et al.. (2012). Chromatin Remodeling Underlies the Senescence-Associated Secretory Phenotype of Tumor Stromal Fibroblasts That Supports Cancer Progression. Cancer Research. 72(9). 2251–2261. 152 indexed citations
9.
Heller, Emanuela, Michelle A. Hurchla, Jingyu Xiang, et al.. (2011). Hedgehog Signaling Inhibition Blocks Growth of Resistant Tumors through Effects on Tumor Microenvironment. Cancer Research. 72(4). 897–907. 66 indexed citations
10.
Choi, Jaebok, Julie Ritchey, Julie L. Prior, et al.. (2010). In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia. Blood. 116(1). 129–139. 249 indexed citations
11.
Sivapackiam, Jothilingam, et al.. (2010). Synthesis, molecular structure, and validation of metalloprobes for assessment of MDR1 P-glycoprotein-mediated functional transport. Dalton Transactions. 39(25). 5842–5842. 21 indexed citations
12.
13.
Pazolli, Ermira, Xianmin Luo, Kelly Carbery, et al.. (2009). Senescent Stromal-Derived Osteopontin Promotes Preneoplastic Cell Growth. Cancer Research. 69(3). 1230–1239. 122 indexed citations
14.
Uluçkan, Özge, Hongju Deng, Wei Zou, et al.. (2009). CD47 Regulates Bone Mass and Tumor Metastasis to Bone. Cancer Research. 69(7). 3196–3204. 67 indexed citations
15.
Pichler, Andrea, Julie L. Prior, Gary D. Luker, & David Piwnica‐Worms. (2008). Generation of a highly inducible Gal4 → Fluc universal reporter mouse for in vivo bioluminescence imaging. Proceedings of the National Academy of Sciences. 105(41). 15932–15937. 25 indexed citations
16.
Uluçkan, Özge, Mark C. Eagleton, Desiree H. Floyd, et al.. (2008). APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice. Journal of Cellular Biochemistry. 104(4). 1311–1323. 48 indexed citations
17.
Nervi, Bruno, Michael P. Rettig, Julie Ritchey, et al.. (2007). Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID β2mnull mice. Experimental Hematology. 35(12). 1823–1838. 52 indexed citations
18.
19.
Zelcer, Noam, et al.. (2005). In vivo RNA Interference–Mediated Ablation of MDR1 P-Glycoprotein. Clinical Cancer Research. 11(12). 4487–4494. 73 indexed citations
20.
Luker, Gary D., et al.. (2003). Bioluminescence Imaging Reveals Systemic Dissemination of Herpes Simplex Virus Type 1 in the Absence of Interferon Receptors. Journal of Virology. 77(20). 11082–11093. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natarajan Muthusamy Breakdown of academic impact, for papers by Pu Zhang Breakdown of academic impact, for papers by Susan D. Spencer Breakdown of academic impact, for papers by Jie Sun Breakdown of academic impact, for papers by Michele Cilli Breakdown of academic impact, for papers by Constantin N. Baxevanis Breakdown of academic impact, for papers by Jamison L. Nourse Breakdown of academic impact, for papers by Kei Tashiro Breakdown of academic impact, for papers by William G. Kerr Breakdown of academic impact, for papers by David Naor
Rankless by CCL
2026